Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AfyaAFYA -3.01%82 3-Year EPS without NRI Growth Rate is 32.30% as of Jun. 2026, which is 24% above its 10-year median of 26.05. GuruFocus rates AFYA with a GF Score™ of 82/100 and a GF Value™ of $20.92 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 180 Education companies, Afya ranks better than 76.11% on this metric.
During the past 12 months, Afya's average EPS without NRI Growth Rate was 24.20% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 32.30% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 28.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 9 years, the highest 3-Year average EPS without NRI Growth Rate of Afya was 52.20% per year. The lowest was 16.70% per year. And the median was 26.05% per year.
Afya (NAS:AFYA) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Afya 3-Year EPS without NRI Growth Rate Related Terms
AFYA vs UTI, PXED, COUR: 3-Year EPS without NRI Growth Rate Comparison
For the Education & Training Services subindustry, Afya's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afya 3-Year EPS without NRI Growth Rate vs Education Industry
For the Education industry and Consumer Defensive sector, Afya's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Afya's 3-Year EPS without NRI Growth Rate falls into.
Afya 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 32.30% mean?
Afya (AFYA) has a 3-Year EPS without NRI Growth Rate of 32.30% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Afya and its competitors. This is 24% above median its historical median of 26.05. Over the past decade, Afya's 3-Year EPS without NRI Growth Rate has ranged from 16.70 to 52.20. According to the industry distribution chart, Afya ranks #43 out of 180 companies in the Education industry, placing it in the top 23.9%.
Is Afya's 3-Year EPS without NRI Growth Rate too high?
Afya's current 3-Year EPS without NRI Growth Rate of 32.30% is 24% above median its 10-year median of 26.05. Over the past 10 years, this metric has ranged from a low of 16.70 to a high of 52.20. The Education industry median 3-Year EPS without NRI Growth Rate is 8.15. Afya's value of 32.30% is 296.3% above this industry median. Based on the distribution chart, Afya ranks #43 out of 180 companies in the Education industry, which is in the top quartile — a strong position relative to peers. Overall, Afya has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Afya's 3-Year EPS without NRI Growth Rate compare to UTI and PXED?
According to the Education industry distribution chart, Afya ranks #43 out of 180 companies for 3-Year EPS without NRI Growth Rate. This places Afya in the top 24% of its industry — outperforming the majority of peers. The industry median 3-Year EPS without NRI Growth Rate is 8.15. Afya's value of 32.30% is 296.3% above this benchmark. Historically, Afya's own 3-Year EPS without NRI Growth Rate has ranged from 16.70 to 52.20 over the past decade. While the company's 10-year median is 26.05 vs. the industry median of 8.15, Afya has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for an Education company?
The median 3-Year EPS without NRI Growth Rate among Education companies is 8.15, based on 180 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afya's current 3-Year EPS without NRI Growth Rate of 32.30% is 296.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Afya and its competitors. For the Education industry, the median 3-Year EPS without NRI Growth Rate is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afya's current 3-Year EPS without NRI Growth Rate is 32.30%, which is 24% above median its own 10-year median of 26.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afya stock overvalued right now?
Based on GuruFocus' analysis, Afya (AFYA) is currently considered Significantly Undervalued. The stock's GF Value™ is $20.92, compared to a current price of $13.85 — trading 33.8% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 32.30%, which is 24% above median its 10-year median of 26.05 and 296.3% above the Education industry median of 8.15. Afya's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Afya (AFYA), the current 3-Year EPS without NRI Growth Rate is 32.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afya (AFYA) Overvalued in 2026?
Based on GuruFocus' analysis, Afya stock appears to be undervalued.
The current stock price of $13.85 is trading 33.8% below its estimated GF Value™ of $20.92.
GuruFocus considers Afya to be Significantly Undervalued.
Key valuation signals for AFYA:
3-Year EPS without NRI Growth Rate: 32.30% (24% above median its 10-year median of 26.05)
GF Value™: $20.92 vs. price of $13.85 (33.8% below fair value)
Industry Position: 296.3% above the Education median (#43 of 180)
No single metric tells the full story. See the AFYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
82GF Score
Get the complete analysis for AFYA
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFYA has been successfully added to your 
